Suppr超能文献

巴罗破裂动脉瘤试验中囊状动脉瘤的十年分析。

Ten-year analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial.

作者信息

Spetzler Robert F, McDougall Cameron G, Zabramski Joseph M, Albuquerque Felipe C, Hills Nancy K, Nakaji Peter, Karis John P, Wallace Robert C

机构信息

Departments of1Neurosurgery and.

2Swedish Neuroscience Institute, Seattle, Washington; and.

出版信息

J Neurosurg. 2019 Mar 8;132(3):771-776. doi: 10.3171/2018.8.JNS181846. Print 2020 Mar 1.

Abstract

OBJECTIVE

The authors present the 10-year results of the Barrow Ruptured Aneurysm Trial (BRAT) for saccular aneurysms. The 1-, 3-, and 6-year results of the trial have been previously reported, as have the 6-year results with respect to saccular aneurysms. This final report comparing the safety and efficacy of clipping versus coiling is limited to an analysis of those patients presenting with subarachnoid hemorrhage (SAH) from a ruptured saccular aneurysm.

METHODS

In the study, 362 patients had saccular aneurysms and were randomized equally to the clipping and the coiling cohorts (181 each). The primary outcome analysis was based on the assigned treatment group; poor outcome was defined as a modified Rankin Scale (mRS) score > 2 and was independently adjudicated. The extent of aneurysm obliteration was adjudicated by a nontreating neuroradiologist.

RESULTS

There was no statistically significant difference in poor outcome (mRS score > 2) or deaths between these 2 treatment arms during the 10 years of follow-up. Of 178 clip-assigned patients with saccular aneurysms, 1 (< 1%) was crossed over to coiling, and 64 (36%) of the 178 coil-assigned patients were crossed over to clipping. After the initial hospitalization, 2 of 241 (0.8%) clipped saccular aneurysms and 23 of 115 (20%) coiled saccular aneurysms required retreatment (p < 0.001). At the 10-year follow-up, 93% (50/54) of the clipped aneurysms were completely obliterated, compared with only 22% (5/23) of the coiled aneurysms (p < 0.001). Two patients had documented rebleeding, both died, and both were in the assigned and treated coiled cohort (2/83); no patient in the clipped cohort (0/175) died (p = 0.04). In 1 of these 2 patients, the hemorrhage was not from the target aneurysm but from an incidental basilar artery aneurysm, which was coiled at the same time.

CONCLUSIONS

There was no significant difference in clinical outcomes between the 2 assigned treatment groups as measured by mRS outcomes or deaths. Clinical outcomes in the patients with posterior circulation aneurysms were better in the coiling group at 1 year, but after 1 year this difference was no longer statistically significant. Rates of complete aneurysm obliteration and rates of retreatment favored patients who actually underwent clipping compared with those who underwent coiling.Clinical trial registration no.: NCT01593267 (clinicaltrials.gov).

摘要

目的

作者展示了巴罗破裂动脉瘤试验(BRAT)针对囊状动脉瘤的10年结果。该试验的1年、3年和6年结果此前已发表,囊状动脉瘤的6年结果也已公布。这份比较夹闭术与血管内栓塞术安全性和有效性的最终报告仅限于分析那些因囊状动脉瘤破裂导致蛛网膜下腔出血(SAH)的患者。

方法

在该研究中,362例患者患有囊状动脉瘤,被平均随机分为夹闭组和血管内栓塞组(每组181例)。主要结局分析基于分配的治疗组;不良结局定义为改良Rankin量表(mRS)评分>2,并由独立判定。动脉瘤闭塞程度由非治疗神经放射科医生判定。

结果

在10年随访期间,这两个治疗组在不良结局(mRS评分>2)或死亡方面无统计学显著差异。在178例分配接受夹闭术的囊状动脉瘤患者中,1例(<1%)转为血管内栓塞术,在178例分配接受血管内栓塞术的患者中,64例(36%)转为夹闭术。初次住院后,241例接受夹闭术的囊状动脉瘤中有2例(0.8%)、115例接受血管内栓塞术的囊状动脉瘤中有23例(20%)需要再次治疗(p<0.001)。在10年随访时,接受夹闭术的动脉瘤中有93%(50/54)完全闭塞,而接受血管内栓塞术的动脉瘤中只有22%(5/23)完全闭塞(p<0.001)。有2例患者记录到再出血,均死亡,且均在分配并接受血管内栓塞术的队列中(2/83);接受夹闭术的队列中无患者死亡(0/175)(p=0.04)。在这2例患者中的1例中,出血并非来自目标动脉瘤,而是来自同时进行血管内栓塞术的基底动脉偶然动脉瘤。

结论

以mRS结局或死亡衡量,两个分配的治疗组临床结局无显著差异。血管内栓塞组后循环动脉瘤患者1年时临床结局较好,但1年后这种差异不再具有统计学显著性。与接受血管内栓塞术的患者相比,实际接受夹闭术的患者动脉瘤完全闭塞率和再次治疗率更高。临床试验注册号:NCT01593267(clinicaltrials.gov)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验